Intracranial spread of Merkel cell carcinoma to the cerebellopontine angle.

Brian Seaman, Steven Brem, Allison Fromm, Aileen Staller, Timothy McCardle, Surbhi Jain

Journal: Journal of cutaneous medicine and surgery 2012;16(1):54-60

PMID: 22417997

Abstract

BACKGROUND

Merkel cell carcinoma (MCC) is a rare, highly malignant, and aggressive dermal neuroendocrine neoplasm that rarely metastasizes to the central nervous system.

OBJECTIVE

To review the current literature regarding treatment of neurometastatic MCC.

METHODS

A case of a 78-year-old male with intracranial extra-axial metastatic MCC involving the left cerebellopontine angle is presented.

RESULTS

A retrosigmoid craniectomy was performed with complete resection of the metastatic focus. Adjuvant treatment included whole-brain radiation therapy followed by etoposide and carboplatin chemotherapy. Seven months postoperatively, the patient was free of metastatic disease.

CONCLUSION

Surgical resection should be performed when feasible to prevent local recurrence. This may be followed by early adjuvant fractionated whole-brain radiotherapy and systemic chemotherapy; however, no clinical trials have been performed to demonstrate a survival benefit.

Address: Department of Neuro-oncology and Pathology, Moffitt Cancer Research Center, Tampa, FL, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.